Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers Results available

Immunogenicity and Safety of Pediatric Vaccines When Administered With Menactra® in Healthy Toddlers

ClinicalTrials.gov ID: NCT00422292

Public ClinicalTrials.gov record NCT00422292. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 10:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Immunogenicity, Safety, and Non-Interference Evaluation of Pediatric Vaccines Administered Concomitantly With Menactra® (Meningococcal [Groups A, C, Y and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine) to Healthy Toddlers

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a modified single-blind, randomized, parallel-group, comparative, multicenter study to test Menactra vaccine in toddlers. Primary Objectives: * To evaluate the antibody responses induced by Measles, Mumps, Rubella, and Varicella (MMRV) vaccine when administered alone or concomitantly with Menactra vaccine. * To evaluate the antibody responses induced by Pneumococcal Conjugated Vaccine (PCV) when administered alone or concomitantly with Menactra vaccine. Observational Objectives: Safety - To describe the safety profile throughout the course of the study from Day 0 up to 6 months after the last study vaccination\[s\]) in subjects in the study groups. Immunogenicity: \- To describe the antibody responses to meningococcal serogroups A, C, Y, and W-135, 30 days after the first and second Menactra vaccine administration in a subset of subjects in the first study group.

Study identification

NCT ID
NCT00422292
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
1,664 participants

Conditions and interventions

Eligibility (public fields only)

Age range
9 Months to 12 Months
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2006 (Type not available)
Primary completion
Jan 2009 (Actual)
Completion
Apr 2009 (Actual)
Last update posted
Apr 14, 2016

2006 – 2009

United States locations

U.S. sites
87
U.S. states
30
U.S. cities
77
Facility City State ZIP Site status
Not listed Tuscaloosa Alabama 35401 —
Not listed Tucson Arizona 85741 —
Not listed Jonesboro Arkansas 72401 —
Not listed Little Rock Arkansas 72205 —
Not listed Atascadero California 93422 —
Not listed Fresno California 93726 —
Not listed Paramount California 90723 —
Not listed Roseville California 95661 —
Not listed Sacramento California 95823 —
Not listed San Jose California 95119 —
Not listed Torrance California 90502 —
Not listed Aurora Colorado 80012 —
Not listed Norwich Connecticut 06360 —
Not listed Viera Florida 32940 —
Not listed West Palm Beach Florida 33409 —
Not listed Dalton Georgia 30721 —
Not listed Marietta Georgia 30062 —
Not listed Tifton Georgia 31794 —
Not listed Woodstock Georgia 30189 —
Not listed Chicago Illinois 60614 —
Not listed Chicago Illinois 60647 —
Not listed Fishers Indiana 46038 —
Not listed Dubuque Iowa 52001 —
Not listed Dubuque Iowa 52002 —
Not listed Owensboro Kentucky 42303 —
Not listed Bossier City Louisiana 71111 —
Not listed Perry Hall Maryland 21128 —
Not listed Woburn Massachusetts 01801 —
Not listed Niles Michigan 49120 —
Not listed Stevensville Michigan 49127 —
Not listed Bridgeton Missouri 63044 —
Not listed Kansas City Missouri 64108 —
Not listed Saint Charles Missouri 63303 —
Not listed St Louis Missouri 63104 —
Not listed Bellevue Nebraska 68123 —
Not listed La Vista Nebraska 68128 —
Not listed Omaha Nebraska 68117 —
Not listed Omaha Nebraska 68124 —
Not listed Omaha Nebraska 68131 —
Not listed Omaha Nebraska 68132 —
Not listed Henderson Nevada 89105 —
Not listed Whitehouse Station New Jersey 08889 —
Not listed Brooklyn New York 11201 —
Not listed Fishkill New York 12524 —
Not listed Hopewell Junction New York 12533 —
Not listed Ithaca New York 14850 —
Not listed Lake Success New York 11021 —
Not listed Mineola New York 11501 —
Not listed New York New York 10016 —
Not listed Poughkeepsie New York 12603 —
Not listed Syracuse New York 13210 —
Not listed Boone North Carolina 28607 —
Not listed Clyde North Carolina 28721 —
Not listed Durham North Carolina 27704 —
Not listed Durham North Carolina 27705 —
Not listed Beachwood Ohio 44122 —
Not listed Cleveland Ohio 44121 —
Not listed Cleveland Ohio 44195 —
Not listed Independence Ohio 44131 —
Not listed Strongsville Ohio 44136 —
Not listed Harleysville Pennsylvania 19438 —
Not listed Hershey Pennsylvania 17033 —
Not listed Pittsburgh Pennsylvania 15220 —
Not listed Sellersville Pennsylvania 18960 —
Not listed Wexford Pennsylvania 15090 —
Not listed Clarksville Tennessee 37043 —
Not listed Kingsport Tennessee 37660 —
Not listed Houston Texas 77004 —
Not listed Longview Texas 75605 —
Not listed San Antonio Texas 78205 —
Not listed San Antonio Texas 78229 —
Not listed Lehi Utah 84043 —
Not listed Ogden Utah 84405 —
Not listed Pleasant Grove Utah 84062 —
Not listed Provo Utah 84604 —
Not listed South Jordan Utah 84095 —
Not listed Springville Utah 84663 —
Not listed St. George Utah 84790 —
Not listed Urem Utah 84057 —
Not listed Charlottesville Virginia 22902 —
Not listed Charlottesville Virginia 22903 —
Not listed Charlottesville Virginia 22911 —
Not listed Midlothian Virginia 23113 —
Not listed Richmond Virginia 23219 —
Not listed Huntington West Virginia 25701 —
Not listed Morgantown West Virginia 26506 —
Not listed Marshfield Wisconsin 54449 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00422292, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 14, 2016 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00422292 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →